Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.
about
Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer.CDK5 in oncology: recent advances and future prospects.Paradoxical activation of alternative pro-survival pathways determines resistance to MEK inhibitors in chronic lymphocytic leukaemia.Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia.
P2860
Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pro-survival signal inhibition ...... Chronic Lymphocytic Leukaemia.
@en
type
label
Pro-survival signal inhibition ...... Chronic Lymphocytic Leukaemia.
@en
prefLabel
Pro-survival signal inhibition ...... Chronic Lymphocytic Leukaemia.
@en
P2093
P2860
P356
P1476
Pro-survival signal inhibition ...... Chronic Lymphocytic Leukaemia.
@en
P2093
Chris Clements
Ghalia Shelmani
Jesvin Samuel
Sandra Germano
Sandrine Jayne
Yixiang Chen
P2860
P304
P356
10.1111/BJH.14285
P407
P577
2016-07-29T00:00:00Z